Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Emergent BioSolutions shares are trading higher after the company announced that the FDA approved the supplemental Biologics License Application for the expansion of the indication for ACAM2000, to include prevention of mpox disease in individuals determined to be at high risk for mpox infection.

Author: Benzinga Newsdesk | August 30, 2024 07:57am

Posted In: EBS